234 related articles for article (PubMed ID: 22692499)
21. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
[TBL] [Abstract][Full Text] [Related]
22. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
[TBL] [Abstract][Full Text] [Related]
23. Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene.
Marodon G; Mouly E; Blair EJ; Frisen C; Lemoine FM; Klatzmann D
Blood; 2003 May; 101(9):3416-23. PubMed ID: 12511423
[TBL] [Abstract][Full Text] [Related]
24. Promising Results with Ex Vivo Lentiviral HSPC Gene Therapy in ADA-SCID.
Am J Med Genet A; 2021 Aug; 185(8):2291-2292. PubMed ID: 34240545
[No Abstract] [Full Text] [Related]
25. Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.
Ebeling P; Bach P; Sorg U; Schneider A; Trarbach T; Dilloo D; Hanenberg H; Niesert S; Seeber S; Moritz T; Flasshove M
J Cancer Res Clin Oncol; 2007 Mar; 133(3):199-209. PubMed ID: 17053889
[TBL] [Abstract][Full Text] [Related]
26. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo.
Herbst F; Ball CR; Tuorto F; Nowrouzi A; Wang W; Zavidij O; Dieter SM; Fessler S; van der Hoeven F; Kloz U; Lyko F; Schmidt M; von Kalle C; Glimm H
Mol Ther; 2012 May; 20(5):1014-21. PubMed ID: 22434137
[TBL] [Abstract][Full Text] [Related]
27. Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeys.
Carbonaro Sarracino D; Tarantal AF; Lee CC; Martinez M; Jin X; Wang X; Hardee CL; Geiger S; Kahl CA; Kohn DB
Mol Ther; 2014 Oct; 22(10):1803-16. PubMed ID: 24925206
[TBL] [Abstract][Full Text] [Related]
28. Correction of SCID-X1 using an enhancerless Vav promoter.
Almarza E; Zhang F; Santilli G; Blundell MP; Howe SJ; Thornhill SI; Bueren JA; Thrasher AJ
Hum Gene Ther; 2011 Mar; 22(3):263-70. PubMed ID: 20887212
[TBL] [Abstract][Full Text] [Related]
29. Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK.
Ng YY; Baert MR; Pike-Overzet K; Rodijk M; Brugman MH; Schambach A; Baum C; Hendriks RW; van Dongen JJ; Staal FJ
Leukemia; 2010 Sep; 24(9):1617-30. PubMed ID: 20574453
[TBL] [Abstract][Full Text] [Related]
30. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.
Mostoslavsky G; Fabian AJ; Rooney S; Alt FW; Mulligan RC
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16406-11. PubMed ID: 17062750
[TBL] [Abstract][Full Text] [Related]
31. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.
De Ravin SS; Wu X; Moir S; Anaya-O'Brien S; Kwatemaa N; Littel P; Theobald N; Choi U; Su L; Marquesen M; Hilligoss D; Lee J; Buckner CM; Zarember KA; O'Connor G; McVicar D; Kuhns D; Throm RE; Zhou S; Notarangelo LD; Hanson IC; Cowan MJ; Kang E; Hadigan C; Meagher M; Gray JT; Sorrentino BP; Malech HL; Kardava L
Sci Transl Med; 2016 Apr; 8(335):335ra57. PubMed ID: 27099176
[TBL] [Abstract][Full Text] [Related]
32. Efficiency of different fragment lengths of the ubiquitous chromatin opening element HNRPA2B1-CBX3 in driving human CD18 gene expression within self-inactivating lentiviral vectors for gene therapy applications.
Gopinath C; Chodisetty S; Ghosh A; Nelson EJR
Gene; 2019 Aug; 710():265-272. PubMed ID: 31200085
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral Gene Therapy for Artemis-Deficient SCID.
Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM
N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.
Cooper AR; Lill GR; Shaw K; Carbonaro-Sarracino DA; Davila A; Sokolic R; Candotti F; Pellegrini M; Kohn DB
Blood; 2017 May; 129(19):2624-2635. PubMed ID: 28351939
[TBL] [Abstract][Full Text] [Related]
35. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
[TBL] [Abstract][Full Text] [Related]
36. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors.
Salmon P; Kindler V; Ducrey O; Chapuis B; Zubler RH; Trono D
Blood; 2000 Nov; 96(10):3392-8. PubMed ID: 11071633
[TBL] [Abstract][Full Text] [Related]
37. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
Adjali O; Marodon G; Steinberg M; Mongellaz C; Thomas-Vaslin V; Jacquet C; Taylor N; Klatzmann D
J Clin Invest; 2005 Aug; 115(8):2287-95. PubMed ID: 16075064
[TBL] [Abstract][Full Text] [Related]
38. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo.
VandenDriessche T; Thorrez L; Naldini L; Follenzi A; Moons L; Berneman Z; Collen D; Chuah MK
Blood; 2002 Aug; 100(3):813-22. PubMed ID: 12130491
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
[TBL] [Abstract][Full Text] [Related]
40. A ubiquitous chromatin opening element prevents transgene silencing in pluripotent stem cells and their differentiated progeny.
Pfaff N; Lachmann N; Ackermann M; Kohlscheen S; Brendel C; Maetzig T; Niemann H; Antoniou MN; Grez M; Schambach A; Cantz T; Moritz T
Stem Cells; 2013 Mar; 31(3):488-99. PubMed ID: 23307570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
